Eupraxia Pharmaceuticals, Inc. (EPRX)
7.50
+0.05
(+0.67%)
USD |
NASDAQ |
Sep 03, 16:00
7.44
-0.06
(-0.80%)
After-Hours: 05:13
Eupraxia Pharmaceuticals Market Cap : 491.06M for Sept. 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 03, 2026 | 491.06M |
| September 02, 2026 | 487.78M |
| September 01, 2026 | 415.11M |
| August 31, 2026 | 422.96M |
| August 28, 2026 | 437.04M |
| August 27, 2026 | 481.89M |
| August 26, 2026 | 486.47M |
| August 25, 2026 | 485.82M |
| August 24, 2026 | 476.65M |
| August 21, 2026 | 440.64M |
| August 20, 2026 | 442.61M |
| August 19, 2026 | 458.97M |
| August 18, 2026 | 448.50M |
| August 17, 2026 | 446.53M |
| August 14, 2026 | 439.99M |
| August 13, 2026 | 436.71M |
| August 12, 2026 | 424.27M |
| August 11, 2026 | 438.68M |
| August 10, 2026 | 436.06M |
| August 07, 2026 | 443.26M |
| August 06, 2026 | 411.65M |
| August 05, 2026 | 400.52M |
| August 04, 2026 | 402.99M |
| August 03, 2026 | 402.37M |
| July 31, 2026 | 395.58M |
| Date | Value |
|---|---|
| July 30, 2026 | 404.85M |
| July 29, 2026 | 369.00M |
| July 28, 2026 | 377.03M |
| July 27, 2026 | 381.36M |
| July 24, 2026 | 359.11M |
| July 23, 2026 | 389.39M |
| July 22, 2026 | 396.81M |
| July 21, 2026 | 394.34M |
| July 20, 2026 | 385.69M |
| July 17, 2026 | 407.32M |
| July 16, 2026 | 380.74M |
| July 15, 2026 | 402.99M |
| July 14, 2026 | 391.87M |
| July 13, 2026 | 397.43M |
| July 10, 2026 | 412.88M |
| July 09, 2026 | 427.10M |
| July 08, 2026 | 427.72M |
| July 07, 2026 | 411.03M |
| July 06, 2026 | 402.99M |
| July 02, 2026 | 413.50M |
| July 01, 2026 | 414.74M |
| June 30, 2026 | 408.55M |
| June 29, 2026 | 407.32M |
| June 26, 2026 | 407.94M |
| June 25, 2026 | 396.19M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Edesa Biotech, Inc. | 45.85M |
| ProMIS Neurosciences, Inc. | 115.68M |
| Arrowhead Pharmaceuticals, Inc. | 12.21B |
| Oncolytics Biotech, Inc. | 106.75M |
| Sangamo Therapeutics, Inc. | 68.85M |
Market Cap Related Metrics
| PEG Ratio | -0.4638 |
| Price to Book Value | 4.826 |
| Price | 7.50 |
| Earnings Yield | -13.13% |
| PEGY Ratio | -0.4638 |